Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 9/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 9/20 | 0.38 |
| ▸ | HTR7 | P34969 | 9/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30874947 | 0.75 | DPP4 (0.39) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874876 | 0.74 | DPP4 (0.39) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL7256889 | 0.73 | DPP4 (0.46) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL17112808 | 0.73 | DPP4 (0.46) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874943 | 0.72 | DPP4 (0.44) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874914 | 0.72 | DPP4 (0.44) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874974 | 0.72 | DPP4 (0.44) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874950 | 0.72 | DPP4 (0.42) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874810 | 0.72 | DPP4 (0.42) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874847 | 0.71 | DPP4 (0.47) | DPP4DPP9HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956985-A | Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof | 梅兹治疗公司 | 2024-04-30 | — | — | CN | disclosed |